How long does CDK4/6 inhibitor therapy take to work for hormone receptor-positive breast cancer?

CDK4/6 inhibitors block proteins that help cells move through the cell cycle. This can slow the growth and division of hormone receptor-positive breast cancer cells. The medicine is commonly used alongside hormone therapy, so your doctor considers the combination when judging benefit.

A response may be reflected in symptoms, examination findings, blood tests or imaging, depending on the stage and treatment goal. Some people notice no immediate change even when the medicine is having an effect. Do not stop treatment because results are not felt from day to day.

Take the inhibitor and hormone therapy according to the prescribed schedule, including any planned breaks. Keep a record of tablets, missed doses and symptoms such as diarrhoea, mouth soreness or tiredness. Attend blood-test appointments so the team can check blood counts, liver function and other safety measures.

Call promptly for fever, chills, unusual bruising or bleeding, yellowing of the skin, severe diarrhoea, breathlessness or a new persistent cough. These symptoms may need treatment changes or urgent assessment, especially if blood counts are low.

Ask when your first scan or clinical review is planned, what improvement the team will measure and how long the current combination will be tried. Check what to do after a missed dose and which side effects should be reported the same day.